Information between 18th March 2025 - 17th April 2025
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Division Votes |
|---|
|
26 Mar 2025 - Tobacco and Vapes Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 285 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 366 Noes - 41 |
|
26 Mar 2025 - Tobacco and Vapes Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 294 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 92 Noes - 303 |
|
26 Mar 2025 - Tobacco and Vapes Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 294 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 72 Noes - 304 |
|
26 Mar 2025 - Tobacco and Vapes Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 301 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 159 Noes - 307 |
|
26 Mar 2025 - Tobacco and Vapes Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 299 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 137 Noes - 304 |
|
26 Mar 2025 - Local Authorities (Changes to Years of Ordinary Elections) (England) Order 2025 - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 11 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 11 Noes - 6 |
|
18 Mar 2025 - Children’s Wellbeing and Schools Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 312 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 167 Noes - 324 |
|
18 Mar 2025 - Children’s Wellbeing and Schools Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 314 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 107 Noes - 324 |
|
18 Mar 2025 - Children’s Wellbeing and Schools Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 311 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 382 Noes - 104 |
|
18 Mar 2025 - Public Authorities (Fraud, Error and Recovery) Bill (Twelfth sitting) - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 9 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 6 Noes - 9 |
|
18 Mar 2025 - Public Authorities (Fraud, Error and Recovery) Bill (Twelfth sitting) - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 9 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 3 Noes - 10 |
|
18 Mar 2025 - Public Authorities (Fraud, Error and Recovery) Bill (Twelfth sitting) - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 10 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 3 Noes - 11 |
|
18 Mar 2025 - Children’s Wellbeing and Schools Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 301 Labour No votes vs 6 Labour Aye votes Tally: Ayes - 77 Noes - 315 |
|
18 Mar 2025 - Children’s Wellbeing and Schools Bill - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 306 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 77 Noes - 313 |
|
19 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 310 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 189 |
|
19 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 308 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 313 Noes - 190 |
|
19 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 307 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 310 Noes - 183 |
|
19 Mar 2025 - Winter Fuel Payment - View Vote Context Johanna Baxter voted No - in line with the party majority and in line with the House One of 289 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 177 Noes - 293 |
|
19 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 312 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 187 |
|
19 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 310 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 314 Noes - 187 |
|
19 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 304 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 307 Noes - 182 |
|
25 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 307 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 312 Noes - 190 |
|
25 Mar 2025 - Non-Domestic Rating (Multipliers and Private Schools) Bill (changed to Non-Domestic Rating (Multipliers) Bill) - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 309 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 320 Noes - 179 |
|
25 Mar 2025 - Great British Energy Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 309 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 314 Noes - 198 |
|
25 Mar 2025 - Non-Domestic Rating (Multipliers and Private Schools) Bill (changed to Non-Domestic Rating (Multipliers) Bill) - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 311 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 319 Noes - 166 |
|
25 Mar 2025 - Non-Domestic Rating (Multipliers and Private Schools) Bill (changed to Non-Domestic Rating (Multipliers) Bill) - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 312 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 320 Noes - 180 |
|
25 Mar 2025 - Non-Domestic Rating (Multipliers and Private Schools) Bill (changed to Non-Domestic Rating (Multipliers) Bill) - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 310 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 180 |
|
25 Mar 2025 - Non-Domestic Rating (Multipliers and Private Schools) Bill (changed to Non-Domestic Rating (Multipliers) Bill) - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 311 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 322 Noes - 117 |
|
25 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 308 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 313 Noes - 194 |
|
25 Mar 2025 - Non-Domestic Rating (Multipliers and Private Schools) Bill (changed to Non-Domestic Rating (Multipliers) Bill) - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 311 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 183 |
|
25 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 308 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 314 Noes - 196 |
|
25 Mar 2025 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 305 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 311 Noes - 192 |
|
2 Apr 2025 - Driving Licences: Zero Emission Vehicles - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 295 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 304 Noes - 101 |
|
2 Apr 2025 - Onshore Wind and Solar Generation - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 299 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 307 Noes - 100 |
|
2 Apr 2025 - Energy Conservation - View Vote Context Johanna Baxter voted Aye - in line with the party majority and in line with the House One of 288 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 349 Noes - 14 |
| Speeches |
|---|
|
Johanna Baxter speeches from: Oral Answers to Questions
Johanna Baxter contributed 1 speech (53 words) Tuesday 8th April 2025 - Commons Chamber HM Treasury |
|
Johanna Baxter speeches from: Business of the House
Johanna Baxter contributed 1 speech (73 words) Thursday 3rd April 2025 - Commons Chamber Leader of the House |
|
Johanna Baxter speeches from: UK-US Trade and Tariffs
Johanna Baxter contributed 1 speech (111 words) Thursday 3rd April 2025 - Commons Chamber Department for Business and Trade |
|
Johanna Baxter speeches from: Oral Answers to Questions
Johanna Baxter contributed 2 speeches (77 words) Wednesday 2nd April 2025 - Commons Chamber Northern Ireland Office |
|
Johanna Baxter speeches from: PIP Changes: Impact on Carer’s Allowance
Johanna Baxter contributed 1 speech (50 words) Thursday 27th March 2025 - Commons Chamber Department for Work and Pensions |
|
Johanna Baxter speeches from: Business of the House
Johanna Baxter contributed 1 speech (189 words) Thursday 27th March 2025 - Commons Chamber Leader of the House |
|
Johanna Baxter speeches from: Spring Statement
Johanna Baxter contributed 1 speech (69 words) Wednesday 26th March 2025 - Commons Chamber HM Treasury |
|
Johanna Baxter speeches from: Oral Answers to Questions
Johanna Baxter contributed 1 speech (79 words) Thursday 20th March 2025 - Commons Chamber Department for Environment, Food and Rural Affairs |
|
Johanna Baxter speeches from: Welfare Reform
Johanna Baxter contributed 1 speech (44 words) Tuesday 18th March 2025 - Commons Chamber Department for Work and Pensions |
| Written Answers |
|---|
|
Medicines and Healthcare products Regulatory Agency and National Institute for Health and Care Research
Asked by: Johanna Baxter (Labour - Paisley and Renfrewshire South) Wednesday 19th March 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether his Department has plans to take steps to streamline approvals processes for the (a) Medicines and Healthcare products Regulatory Agency and (ii) National Institute for Health and Care Research. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Medicines and Healthcare products Regulatory Agency (MHRA) continues to optimise its performance in delivering efficient and predictable services which meet stakeholders’ expectations, for the benefit of patients and public health and the Life Sciences. The Agency has been working in close collaboration with health system partners and industry to ensure that robust, appropriate and prompt decisions are made. In March 2024, the MHRA published new guidance in how medicines will be assessed to improve the robustness and rapid decisions, which it can be seen, has a significantly positive effect. The Agency has an ongoing system for review of licencing pathways and has recently launch the consultation for Personalised Immunotherapies for Cancer which can be used to drive discussion forward as to how to enable fast patient benefit of new and novel technologies. The National Institute for Health and Care Research (NIHR) continues to work collaboratively across Government and with key stakeholders to ensure it has optimal systems and processes to support the delivery of impactful and timely research for patient and public benefit. For example, the NIHR has recently launched a new single awards management system for the NIHR underpinned by optimised processes which will streamline operations, enable data sharing and reduce duplicate information requests. |
|
Health Services: Immunosuppression
Asked by: Johanna Baxter (Labour - Paisley and Renfrewshire South) Wednesday 2nd April 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support immunocompromised people. Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care) NHS England Specialised Commissioning has recently updated the specialist immunology service specification for adults with deficient immune systems, named the Specialist immunology services for adults with deficient immune systems. This sets out the standards of care that providers of specialist immunology services are expected to meet, including with regards to treatment and monitoring. Further information on the service specification is available at the following link: The clinical commissioning policy for the use of therapeutic immunoglobulin in England has also recently been updated. The updated document describes all conditions for which therapeutic immunoglobulin is commissioned, including autoimmune conditions, and provides details on the role, dose, and place of therapeutic immunoglobulin in the treatment pathway for individual indications, alongside possible alternative treatment options for use of therapeutic immunoglobulin in both adults and children. Further information on the policy is available at the following link:
Sub Regional Immunoglobulin Assessment Panels (SRIAPs) are in place to provide immunoglobulin stewardship and oversight in line with this policy. In April 2025, a new framework for the supply of immunoglobulin will begin. In March 2025, NHS England Specialised Commissioning provided advice to the SRIAPs regarding patient access to immunoglobulin products, with the introduction of the new framework.
Neither the Department nor NHS England hold data centrally on the exact numbers of those who are clinically defined as immunocompromised. However, a recently published paper in the Journal of Infection identified 477,335 immunocompromised individuals aged 12 years old and over in England. This research paper is available at the following link: https://www.sciencedirect.com/science/article/pii/S016344532500026X NHS England Specialised Commissioning is developing a patient information sheet to outline the changes to the range of immunoglobulin products available on the National Health Service. It is intended to support patients who rely on immunoglobulin treatment and may be required to switch to a different immunoglobulin product. This will be shared with patient organisations and clinical teams in April 2025. The UK Health Security Agency (UKHSA) is committed to working with partners, including NHS England and the Department, to protect the health of immunocompromised patients in the context of infectious disease hazards. Engaging with the Immunocompromised Coalition and other charities supporting vulnerable individuals, in partnership with the Department and the NHS as part of pandemic preparedness, is an important activity for the UKHSA. It enables the prompt implementation of appropriate protective measures with relevant, scalable additional support in the event of a pandemic or another emergency.
https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk |
|
Immunosuppression: Departmental Coordination
Asked by: Johanna Baxter (Labour - Paisley and Renfrewshire South) Wednesday 2nd April 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of establishing a cross-departmental taskforce for for immunocompromised patients. Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care) NHS England Specialised Commissioning has recently updated the specialist immunology service specification for adults with deficient immune systems, named the Specialist immunology services for adults with deficient immune systems. This sets out the standards of care that providers of specialist immunology services are expected to meet, including with regards to treatment and monitoring. Further information on the service specification is available at the following link: The clinical commissioning policy for the use of therapeutic immunoglobulin in England has also recently been updated. The updated document describes all conditions for which therapeutic immunoglobulin is commissioned, including autoimmune conditions, and provides details on the role, dose, and place of therapeutic immunoglobulin in the treatment pathway for individual indications, alongside possible alternative treatment options for use of therapeutic immunoglobulin in both adults and children. Further information on the policy is available at the following link:
Sub Regional Immunoglobulin Assessment Panels (SRIAPs) are in place to provide immunoglobulin stewardship and oversight in line with this policy. In April 2025, a new framework for the supply of immunoglobulin will begin. In March 2025, NHS England Specialised Commissioning provided advice to the SRIAPs regarding patient access to immunoglobulin products, with the introduction of the new framework.
Neither the Department nor NHS England hold data centrally on the exact numbers of those who are clinically defined as immunocompromised. However, a recently published paper in the Journal of Infection identified 477,335 immunocompromised individuals aged 12 years old and over in England. This research paper is available at the following link: https://www.sciencedirect.com/science/article/pii/S016344532500026X NHS England Specialised Commissioning is developing a patient information sheet to outline the changes to the range of immunoglobulin products available on the National Health Service. It is intended to support patients who rely on immunoglobulin treatment and may be required to switch to a different immunoglobulin product. This will be shared with patient organisations and clinical teams in April 2025. The UK Health Security Agency (UKHSA) is committed to working with partners, including NHS England and the Department, to protect the health of immunocompromised patients in the context of infectious disease hazards. Engaging with the Immunocompromised Coalition and other charities supporting vulnerable individuals, in partnership with the Department and the NHS as part of pandemic preparedness, is an important activity for the UKHSA. It enables the prompt implementation of appropriate protective measures with relevant, scalable additional support in the event of a pandemic or another emergency.
https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk |
|
Health Services: Immunosuppression
Asked by: Johanna Baxter (Labour - Paisley and Renfrewshire South) Wednesday 2nd April 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, when his Department last issued guidance for clinicians on treating immunocompromised patients in health settings. Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care) NHS England Specialised Commissioning has recently updated the specialist immunology service specification for adults with deficient immune systems, named the Specialist immunology services for adults with deficient immune systems. This sets out the standards of care that providers of specialist immunology services are expected to meet, including with regards to treatment and monitoring. Further information on the service specification is available at the following link: The clinical commissioning policy for the use of therapeutic immunoglobulin in England has also recently been updated. The updated document describes all conditions for which therapeutic immunoglobulin is commissioned, including autoimmune conditions, and provides details on the role, dose, and place of therapeutic immunoglobulin in the treatment pathway for individual indications, alongside possible alternative treatment options for use of therapeutic immunoglobulin in both adults and children. Further information on the policy is available at the following link:
Sub Regional Immunoglobulin Assessment Panels (SRIAPs) are in place to provide immunoglobulin stewardship and oversight in line with this policy. In April 2025, a new framework for the supply of immunoglobulin will begin. In March 2025, NHS England Specialised Commissioning provided advice to the SRIAPs regarding patient access to immunoglobulin products, with the introduction of the new framework.
Neither the Department nor NHS England hold data centrally on the exact numbers of those who are clinically defined as immunocompromised. However, a recently published paper in the Journal of Infection identified 477,335 immunocompromised individuals aged 12 years old and over in England. This research paper is available at the following link: https://www.sciencedirect.com/science/article/pii/S016344532500026X NHS England Specialised Commissioning is developing a patient information sheet to outline the changes to the range of immunoglobulin products available on the National Health Service. It is intended to support patients who rely on immunoglobulin treatment and may be required to switch to a different immunoglobulin product. This will be shared with patient organisations and clinical teams in April 2025. The UK Health Security Agency (UKHSA) is committed to working with partners, including NHS England and the Department, to protect the health of immunocompromised patients in the context of infectious disease hazards. Engaging with the Immunocompromised Coalition and other charities supporting vulnerable individuals, in partnership with the Department and the NHS as part of pandemic preparedness, is an important activity for the UKHSA. It enables the prompt implementation of appropriate protective measures with relevant, scalable additional support in the event of a pandemic or another emergency.
https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk |
|
Immunosuppression
Asked by: Johanna Baxter (Labour - Paisley and Renfrewshire South) Wednesday 2nd April 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, how many people in the United Kingdom are clinically defined as immunocompromised. Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care) NHS England Specialised Commissioning has recently updated the specialist immunology service specification for adults with deficient immune systems, named the Specialist immunology services for adults with deficient immune systems. This sets out the standards of care that providers of specialist immunology services are expected to meet, including with regards to treatment and monitoring. Further information on the service specification is available at the following link: The clinical commissioning policy for the use of therapeutic immunoglobulin in England has also recently been updated. The updated document describes all conditions for which therapeutic immunoglobulin is commissioned, including autoimmune conditions, and provides details on the role, dose, and place of therapeutic immunoglobulin in the treatment pathway for individual indications, alongside possible alternative treatment options for use of therapeutic immunoglobulin in both adults and children. Further information on the policy is available at the following link:
Sub Regional Immunoglobulin Assessment Panels (SRIAPs) are in place to provide immunoglobulin stewardship and oversight in line with this policy. In April 2025, a new framework for the supply of immunoglobulin will begin. In March 2025, NHS England Specialised Commissioning provided advice to the SRIAPs regarding patient access to immunoglobulin products, with the introduction of the new framework.
Neither the Department nor NHS England hold data centrally on the exact numbers of those who are clinically defined as immunocompromised. However, a recently published paper in the Journal of Infection identified 477,335 immunocompromised individuals aged 12 years old and over in England. This research paper is available at the following link: https://www.sciencedirect.com/science/article/pii/S016344532500026X NHS England Specialised Commissioning is developing a patient information sheet to outline the changes to the range of immunoglobulin products available on the National Health Service. It is intended to support patients who rely on immunoglobulin treatment and may be required to switch to a different immunoglobulin product. This will be shared with patient organisations and clinical teams in April 2025. The UK Health Security Agency (UKHSA) is committed to working with partners, including NHS England and the Department, to protect the health of immunocompromised patients in the context of infectious disease hazards. Engaging with the Immunocompromised Coalition and other charities supporting vulnerable individuals, in partnership with the Department and the NHS as part of pandemic preparedness, is an important activity for the UKHSA. It enables the prompt implementation of appropriate protective measures with relevant, scalable additional support in the event of a pandemic or another emergency.
https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk |
|
Health Services: Immunosuppression
Asked by: Johanna Baxter (Labour - Paisley and Renfrewshire South) Wednesday 2nd April 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, when did his Department last issue guidance to patients that are immunocompromised. Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care) NHS England Specialised Commissioning has recently updated the specialist immunology service specification for adults with deficient immune systems, named the Specialist immunology services for adults with deficient immune systems. This sets out the standards of care that providers of specialist immunology services are expected to meet, including with regards to treatment and monitoring. Further information on the service specification is available at the following link: The clinical commissioning policy for the use of therapeutic immunoglobulin in England has also recently been updated. The updated document describes all conditions for which therapeutic immunoglobulin is commissioned, including autoimmune conditions, and provides details on the role, dose, and place of therapeutic immunoglobulin in the treatment pathway for individual indications, alongside possible alternative treatment options for use of therapeutic immunoglobulin in both adults and children. Further information on the policy is available at the following link:
Sub Regional Immunoglobulin Assessment Panels (SRIAPs) are in place to provide immunoglobulin stewardship and oversight in line with this policy. In April 2025, a new framework for the supply of immunoglobulin will begin. In March 2025, NHS England Specialised Commissioning provided advice to the SRIAPs regarding patient access to immunoglobulin products, with the introduction of the new framework.
Neither the Department nor NHS England hold data centrally on the exact numbers of those who are clinically defined as immunocompromised. However, a recently published paper in the Journal of Infection identified 477,335 immunocompromised individuals aged 12 years old and over in England. This research paper is available at the following link: https://www.sciencedirect.com/science/article/pii/S016344532500026X NHS England Specialised Commissioning is developing a patient information sheet to outline the changes to the range of immunoglobulin products available on the National Health Service. It is intended to support patients who rely on immunoglobulin treatment and may be required to switch to a different immunoglobulin product. This will be shared with patient organisations and clinical teams in April 2025. The UK Health Security Agency (UKHSA) is committed to working with partners, including NHS England and the Department, to protect the health of immunocompromised patients in the context of infectious disease hazards. Engaging with the Immunocompromised Coalition and other charities supporting vulnerable individuals, in partnership with the Department and the NHS as part of pandemic preparedness, is an important activity for the UKHSA. It enables the prompt implementation of appropriate protective measures with relevant, scalable additional support in the event of a pandemic or another emergency.
https://www.gov.uk/government/publications/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk/covid-19-guidance-for-people-whose-immune-system-means-they-are-at-higher-risk |
| Written Answers |
|---|
|
Unmanned Air Systems: Procurement
Asked by: James Cartlidge (Conservative - South Suffolk) Monday 24th March 2025 Question to the Ministry of Defence: To ask the Secretary of State for Defence, what the target in service date is for MQ-9B Protector. Answered by Maria Eagle - Minister of State (Ministry of Defence) I refer the hon Member to the answer I gave to Question 25381 on 28 January 2025, to the hon Member for Paisley and Renfrewshire South (Johanna Baxter). There has been no delay to the Protector Programme In-Service date. |
|
Unmanned Air Systems: Procurement
Asked by: James Cartlidge (Conservative - South Suffolk) Monday 24th March 2025 Question to the Ministry of Defence: To ask the Secretary of State for Defence, whether there has been a delay to the in-service date for MQ-9B Protector. Answered by Maria Eagle - Minister of State (Ministry of Defence) I refer the hon Member to the answer I gave to Question 25381 on 28 January 2025, to the hon Member for Paisley and Renfrewshire South (Johanna Baxter). There has been no delay to the Protector Programme In-Service date. |
| Bill Documents |
|---|
|
Apr. 09 2025
Notices of Amendments as at 9 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 08 2025
Public Bill Committee Amendments as at 8 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 07 2025
Notices of Amendments as at 7 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 04 2025
Notices of Amendments as at 4 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 03 2025
Public Bill Committee Amendments as at 3 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 03 2025
Public Bill Committee Amendments as at 3 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 02 2025
Notices of Amendments as at 2 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 02 2025
Notices of Amendments as at 2 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 01 2025
Public Bill Committee Amendments as at 1 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Apr. 01 2025
Public Bill Committee Amendments as at 1 April 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 31 2025
Notices of Amendments as at 31 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 28 2025
Notices of Amendments as at 28 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 27 2025
Public Bill Committee Amendments as at 27 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 26 2025
Notices of Amendments as at 26 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 26 2025
Notices of Amendments as at 26 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 25 2025
Notices of Amendments as at 25 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 25 2025
Notices of Amendments as at 25 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 24 2025
Notices of Amendments as at 24 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 24 2025
Notices of Amendments as at 24 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 21 2025
Notices of Amendments as at 21 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
|
Mar. 21 2025
Notices of Amendments as at 21 March 2025 Crime and Policing Bill 2024-26 Amendment Paper Found: Gill Furniss Katrina Murray Lillian Jones David Smith Joani Reid Euan Stainbank Jo White Johanna Baxter |
| Calendar |
|---|
|
Tuesday 1st April 2025 9 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Reforming Jobcentres At 9:00am: Oral evidence Rt Hon Andy Burnham - Mayor at Greater Manchester Combined Authority (GMCA) At 10:00am: Oral evidence Lauren McKechnie - Chief Executive at Age UK Bolton Paul McGarry - Head at Greater Manchester Combined Authority’s Ageing Hub Jo Volpe at Leeds Older People’s Forum Jo Rowlands - Head of Financial Inclusion at Leeds City Council Trish Martin - Advice Services Manager at Southway Housing At 11:00am: Oral evidence Sue Forster - Welfare Benefits Coordinator at Citizens Advice Liverpool Idowu Khadijat Morafa - Founder and Director at Across Ummah CIC View calendar - Add to calendar |
|
Tuesday 1st April 2025 9 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Reforming Jobcentres At 9:00am: Oral evidence Rt Hon Andy Burnham - Mayor of Greater Manchester at Greater Manchester Combined Authority (GMCA) At 10:00am: Oral evidence Lauren McKechnie - Chief Executive at Age UK Bolton Paul McGarry - Head at Greater Manchester Combined Authority’s Ageing Hub Jo Volpe at Leeds Older People’s Forum Jo Rowlands - Head of Financial Inclusion at Leeds City Council Trish Martin - Advice Services Manager at Southway Housing At 11:00am: Oral evidence Sue Forster - Welfare Benefits Coordinator at Citizens Advice Liverpool Idowu Khadijat Morafa - Founder and Director at Across Ummah CIC View calendar - Add to calendar |
|
Tuesday 1st April 2025 9 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Reforming Jobcentres At 9:00am: Oral evidence Rt Hon Andy Burnham - Mayor of Greater Manchester at Greater Manchester Combined Authority (GMCA) At 10:00am: Oral evidence Lauren McKechnie - Chief Executive at Age UK Bolton Paul McGarry - Head at Greater Manchester Combined Authority’s Ageing Hub Jo Rowlands - Head of Financial Inclusion at Leeds City Council Trish Martin - Advice Services Manager at Southway Housing Jo Volpe - Chief Executive at Leeds Older People’s Forum At 11:00am: Oral evidence Sue Forster - Welfare Benefits Coordinator at Citizens Advice Liverpool Idowu Khadijat Morafa - Founder and Director at Across Ummah CIC View calendar - Add to calendar |
|
Tuesday 1st April 2025 9 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Reforming Jobcentres At 9:00am: Oral evidence Rt Hon Andy Burnham - Mayor of Manchester at Greater Manchester Combined Authority (GMCA) At 10:00am: Oral evidence Paul McGarry - Head at Greater Manchester Ageing Hub Mrs Jo Volpe - Chief Executive at Leeds Older People’s Forum Jo Rowlands - Financial Inclusion Manager at Leeds City Council View calendar - Add to calendar |
|
Tuesday 1st April 2025 9 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Reforming Jobcentres View calendar - Add to calendar |
|
Wednesday 26th March 2025 8:30 a.m. Work and Pensions Committee - Oral evidence Subject: Pensioner Poverty: challenges and mitigations At 9:30am: Oral evidence Dr Juliet Stone - Research Fellow at Centre for Research in Social Policy, Loughborough University Dr Kingsley Purdam - Lecturer, Social Statistics at Manchester University Professor Matt Padley - Co-Director of the Centre for Research in Social Policy at Loughborough University At 10:30am: Oral evidence Gary Vaux - Head of Money Advice at Hertfordshire County Council Gareth Morgan - CEO at Ferret Information Systems Daphne Hall - Co Chair at National Association of Welfare Rights Advisers (NAWRA) View calendar - Add to calendar |
|
Wednesday 26th March 2025 8:30 a.m. Work and Pensions Committee - Private Meeting View calendar - Add to calendar |
|
Wednesday 26th March 2025 8:30 a.m. Work and Pensions Committee - Oral evidence Subject: Pensioner Poverty: challenges and mitigations At 9:30am: Oral evidence Dr Juliet Stone - Research Fellow at Centre for Research in Social Policy, Loughborough University Dr Kingsley Purdam - Lecturer, Social Statistic at University of Manchester Professor Matt Padley At 10:30am: Oral evidence Gary Vaux - Head of Money Advice at Hertfordshire County Council Gareth Morgan Daphne Hall - Co Chair at National Association of Welfare Rights Advisers (NAWRA) View calendar - Add to calendar |
|
Wednesday 23rd April 2025 8:30 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Reforming Jobcentres At 9:30am: Oral evidence Abdi Mohamed - Head of Policy, Campaigns and Public Affairs at Scope Balbir Kaur Chatrik - Director of Policy and Communications at Centrepoint Sam Reid - Research Manage at Migrant Help Liz Sewell - Director at Belina Grow At 10:30am: Oral evidence Martin Cavanagh - PCS President at PCS Angela Grant - PCS DWP President at PCS Andrew McGregor - Chair of Careers Forum at UNISON View calendar - Add to calendar |
|
Tuesday 22nd April 2025 3:30 p.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Pathways to Work At 4:00pm: Oral evidence Professor Ben Geiger - Professor in Social Science and Health at King’s College London Tom Pollard - Head of Social Policy at New Economics Foundation Jean-André Prager - Senior Fellow at Policy Exchange Ruth Curtice - Chief Executive at Resolution Foundation At 5:00pm: Oral evidence Ruth Patrick - Professor of Social Policy at University of York Iain Porter - Senior Policy Adviser at Joseph Rowntree Foundation Angela Matthews - Director of Public Policy and Research at Business Disability Forum View calendar - Add to calendar |
|
Wednesday 23rd April 2025 8:30 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Reforming Jobcentres At 9:30am: Oral evidence Abdi Mohamed - Head of Policy, Campaigns and Public Affairs at Scope Balbir Kaur Chatrik - Director of Policy and Communications at Centrepoint Sam Reid - Research Manager at Migrant Help Liz Sewell - Director at Belina Grow At 10:30am: Oral evidence Martin Cavanagh - PCS President at PCS Angela Grant - PCS DWP President at PCS Andrew McGregor - Chair of Careers Forum at UNISON View calendar - Add to calendar |
|
Wednesday 30th April 2025 9 a.m. Work and Pensions Committee - Oral evidence Subject: Pensioner Poverty: challenges and mitigations View calendar - Add to calendar |
|
Wednesday 30th April 2025 8:30 a.m. Work and Pensions Committee - Oral evidence Subject: Pensioner Poverty: challenges and mitigations View calendar - Add to calendar |
|
Wednesday 30th April 2025 8:30 a.m. Work and Pensions Committee - Oral evidence Subject: Pensioner Poverty: challenges and mitigations At 9:30am: Oral evidence Professor Sir Michael Marmot - Director at UCL Institute of Health Equity At 10:15am: Oral evidence Dr David Attwood - GP Partner at Pathfields Medical Group At 10:35am: Oral evidence Dr Ruth Law - Honorary Secretary at British Geriatric Society David Finch - Assistant Director of the Healthy Lives Team at The Health Foundation Toby North - Head of Public Affairs at Marie Curie View calendar - Add to calendar |
|
Wednesday 30th April 2025 8:30 a.m. Work and Pensions Committee - Oral evidence Subject: Pensioner Poverty: challenges and mitigations At 9:30am: Oral evidence Professor Sir Michael Marmot - Director at UCL Institute of Health Equity At 10:15am: Oral evidence Dr David Attwood - GP Partner at Pathfields Medical Group At 10:35am: Oral evidence Dr Ruth Law - Honorary Secretary and Honorary Secretary at The British Geriatrics Society David Finch - Assistant Director of the Healthy Lives Team at The Health Foundation Toby North - Head of Public Affairs at Marie Curie View calendar - Add to calendar |
|
Wednesday 7th May 2025 9:15 a.m. Work and Pensions Committee - Oral evidence Subject: Get Britain Working: Pathways to Work At 9:30am: Oral evidence James Taylor - Executive Director at Scope Mikey Erhardt - Campaigns and Policy Officer at Disability Rights UK Ellen Clifford - Coordinator at Disabled People Against Cuts Jonathan Andrew - Head of Public Affairs at Rethink Mental Illness At 10:30am: Oral evidence Dr Lucy Foulkes - Academic Psychologist at Department of Experimental Psychology, University of Oxford David Finch - Assistant Director, Healthy Lives Directorate at Health Foundation Professor Ben Barr - Professor in Applied Public Health Research at University of Liverpool View calendar - Add to calendar |
| Select Committee Inquiry |
|---|
|
3 Apr 2025
Get Britain Working: Pathways to Work Work and Pensions Committee (Select) Not accepting submissions The Work and Pensions Committee is undertaking a short inquiry into the impact of the Government’s proposals to reform the disability and health related benefits system, as set out in the Pathways to Work Green Paper. The Committee is not putting out a call for evidence, but the terms of reference are:
|